Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Abstract Amyloid plaques and tau tangles are pathological hallmarks of Alzheimer’s disease (AD). Parkinson’s disease (PD) results from the accumulation of α-synuclein. TAR DNA-binding protein (TDP-43) and total tau protein (T-Tau) play roles in FTD pathology. All of the pathological evidence was fou...
Main Authors: | Pai-Yi Chiu, Fu-Chi Yang, Ming-Jang Chiu, Wei-Che Lin, Cheng-Hsien Lu, Shieh-Yueh Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-22647-6 |
Similar Items
-
Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
by: Chin-Hsien Lin, et al.
Published: (2018-04-01) -
Presenilins in Alzheimer’s disease and frontotemporal dementia
by: Shen Jie
Published: (2012-02-01) -
Dementia: Not Only Alzheimer’s disease, an Eye on Frontotemporal Dementia
by: Daniela Galimberti, et al.
Published: (2013-08-01) -
Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
by: Giulia Giacomucci, et al.
Published: (2021-01-01) -
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
by: Wang Pan, et al.
Published: (2020-05-01)